financetom
Business
financetom
/
Business
/
What's Going On With Tonix Pharmaceuticals (TNXP) Stock?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
What's Going On With Tonix Pharmaceuticals (TNXP) Stock?
Sep 9, 2024 4:09 PM

Tonix Pharmaceuticals Holding Corp ( TNXP ) shares are trading higher by 20% to 17 cents during Monday’s session after the company announced data on the potential mpox vaccine TNX-801 in the “Using Synthetic Biology To Battle Mpox” talk at an immunology symposium at the University of Alberta.

What Happened: The presentation highlighted TNX-801, an attenuated live-virus horsepox vaccine designed to protect against mpox (formerly monkeypox).

The company says TNX-801 offers single-dose protection and improved tolerability compared to 20th-century vaccines. It more closely resembles 19th-century vaccinia vaccines, which were effective against smallpox and long-lasting.

The company emphasized that TNX-801 could be more advantageous than existing mpox vaccines like ACAM2000 and Jynneos, offering better durability, fewer side effects, and simpler storage requirements.

Tonix says preclinical studies showed TNX-801 protects animals against lethal monkeypox challenges and reduces virus shedding, suggesting it could block transmission.

Tonix is meanwhile collaborating with Bilthoven Biologics to develop GMP manufacturing processes for TNX-801.

Read Also: Apple’s iPhone 16 Launch: JPMorgan Says ‘Staggered Pricing Approach’ Could Offset Rising Chip, Memory Costs

How To Buy TNXP Stock

By now you're likely curious about how to participate in the market for Tonix Pharmaceuticals ( TNXP ) – be it to purchase shares, or even attempt to bet against the company.

Buying shares is typically done through a brokerage account. You can find a list of possible trading platforms here. Many will allow you to buy ‘fractional shares,' which allows you to own portions of stock without buying an entire share. For example, some stock, like Berkshire Hathaway, can cost thousands of dollars to own just one share. However, if you only want to invest a fraction of that, brokerages will allow you to do so.

If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to ‘go short' a share of stock by lending you the shares to sell. The process of shorting a stock can be found at this resource. Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading – either way it allows you to profit off of the share price decline.

According to data from Benzinga Pro, TNXP has a 52-week high of $29.76 and a 52-week low of $0.13.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Jazz Pharmaceuticals Stock Rallies On Positive Phase 3 Trial Results for Ziihera In Advanced Gastroesophageal Cancer
Jazz Pharmaceuticals Stock Rallies On Positive Phase 3 Trial Results for Ziihera In Advanced Gastroesophageal Cancer
Nov 17, 2025
Jazz Pharmaceuticals Plc ( JAZZ ) shares are popping on Monday following the company’s positive results of its Phase 3 HERIZON-GEA-01 trial, which assessed Ziihera in combination with chemotherapy, with or without the PD-1 inhibitor Tevimbra, as a first-line treatment for HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). What Happened: When compared to the control group that received trastuzumab...
Target May Tighten 2025 Outlook as Q3 Comps Stay Weak, Oppenheimer Says
Target May Tighten 2025 Outlook as Q3 Comps Stay Weak, Oppenheimer Says
Nov 17, 2025
02:46 PM EST, 11/17/2025 (MT Newswires) -- Target ( TGT ) is likely to post soft Q3 on Wednesday with comparable sales down about 2% and could narrow its fiscal 2025 earnings per share guidance toward the low end of its $7 to $9 range, Oppenheimer said Monday in a pre-results report. Oppenheimer said it added conservatism to its Q4...
German Navy to purchase C$1 billion Canadian combat management system, Canada's trade minister says
German Navy to purchase C$1 billion Canadian combat management system, Canada's trade minister says
Nov 17, 2025
(Reuters) -The German Navy will purchase Lockheed Martin Canada's combat management system CMS 330 for more than C$1 billion, Canadian trade minister Maninder Sidhu announced Monday. The selection of Lockheed Martin Canada's CMS 330 by the German Navy is a testament to our world-class defence technologies and the value of government-to-government partnerships, Sidhu said in a statement. ...
Jones Lang LaSalle Offers Steady Growth Outlook, UBS Says
Jones Lang LaSalle Offers Steady Growth Outlook, UBS Says
Nov 17, 2025
02:58 PM EST, 11/17/2025 (MT Newswires) -- Jones Lang LaSalle ( JLL ) is set to benefit from improving industry tailwinds amid attractive valuation after its Q3 results, UBS Securities said in a Sunday note. The report pointed to an outlook downgrade for its Real Estate Management Services segment for the next several quarters while Q3 margin expansion disappointed, similar...
Copyright 2023-2026 - www.financetom.com All Rights Reserved